|
|
||||||||
From the Molecular Genetics Unit (C.P.-R., A.S.), National Institute on Aging, NIH, Bethesda, MD; Department of Neurology (O.D., A.Y.), Faculty of Medicine, Mersin University, Mersin, Turkey; and Department of Molecular Neuroscience (H.H.), Institute of Neurology, Queen Square, London, UK.
Address correspondence and reprint requests to Dr. C. Paisan-Ruiz, National Institutes of Health, 35 Lincoln Drive, Building 35, Room 1A1015, Bethesda, MD 20824
Background: Autosomal recessive hereditary spastic paraplegia (ARHSP) with thin corpus callosum (TCC) is a common form of complex hereditary spastic paraplegia. The genetic lesion underlying ARHSP-TCC was localized to chromosome 15q13-q15 and given the designation SPG11. Recently, the gene encoding spatacsin (KIAA1840) has been shown to contain mutations that underlie the majority of ARHSP-TCC cases.
Methods: We present a complete analysis of the 40 coding exons of this gene in patients with sporadic (n = 25) or familial (20 probands) complex hereditary spastic paraplegia with and without thinning of the corpus callosum.
Results: We identified seven mutations, including deletions, insertions, and nonsense mutations, which were all predicted to lead to premature truncation of the protein.
Conclusion: We conclude that mutations on KIAA1840 are frequent in complex autosomal recessive hereditary spastic paraplegia but an infrequent cause of sporadic complex hereditary spastic paraplegia.
GLOSSARY: ARHSP = autosomal recessive hereditary spastic paraplegia; HSP = hereditary spastic paraplegia; TCC = thin corpus callosum.
C.Paisan-Ruiz{at}ion.ucl.ac.uk
Supplemental data at www.neurology.org
Editorial, page 1375
e-Pub ahead of print on March 12, 2008, at www.neurology.org.
Supported by the Intramural Program of the National Institute on Aging, NIH, Department of Health and Human Services. H.H. holds a Medical Research Council clinician scientist fellowship.
Disclosure: The authors report no conflicts of interest.
Received June 18, 2007. Accepted in final form September 14, 2007.
This article has been cited by other articles:
![]() |
C Crimella, A Arnoldi, F Crippa, M L Mostacciuolo, F Boaretto, M Sironi, M G. D'Angelo, S Manzoni, L Piccinini, A C Turconi, et al. Point mutations and a large intragenic deletion in SPG11 in complicated spastic paraplegia without thin corpus callosum J. Med. Genet., May 1, 2009; 46(5): 345 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Brugman, J. H. Veldink, H. Franssen, M. de Visser, J. M. B.V. de Jong, C. G. Faber, B. H. P. Kremer, H. J. Schelhaas, P. A. van Doorn, J. J. G. M. Verschuuren, et al. Differentiation of Hereditary Spastic Paraparesis From Primary Lateral Sclerosis in Sporadic Adult-Onset Upper Motor Neuron Syndromes Arch Neurol, April 1, 2009; 66(4): 509 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hedera and O. Bandmann Complicated autosomal recessive hereditary spastic paraplegia: A complex picture is emerging Neurology, April 15, 2008; 70(16_Part_2): 1375 - 1376. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |